| http://dbpedia.org/ontology/abstract
|
Oncolytics Biotech Inc. is a Canadian comp … Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.ough innate and adaptive immune responses.
|
| http://dbpedia.org/ontology/foundingYear
|
1998
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://dl.dropboxusercontent.com/u/38536036/ONCY%20PFIC/ONCY_PFIC.pdf +
, http://www.oncolyticsbiotech.com/ +
, http://www.oncolyticsbiotech.com/for-investors/rss-feeds/default.aspx +
, http://www.oncolyticsbiotech.com +
|
| http://dbpedia.org/ontology/wikiPageID
|
28902690
|
| http://dbpedia.org/ontology/wikiPageLength
|
20060
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1114886378
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Natural_killer_cell +
, http://dbpedia.org/resource/Calgary +
, http://dbpedia.org/resource/Pomalidomide +
, http://dbpedia.org/resource/Alberta +
, http://dbpedia.org/resource/Public_company +
, http://dbpedia.org/resource/Passive_foreign_investment_company +
, http://dbpedia.org/resource/Fast_track_%28FDA%29 +
, http://dbpedia.org/resource/Paclitaxel +
, http://dbpedia.org/resource/Northwestern_University +
, http://dbpedia.org/resource/Pembrolizumab +
, http://dbpedia.org/resource/Gemcitabine +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_1998 +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Toronto_Stock_Exchange +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_Canada +
, http://dbpedia.org/resource/Canada +
, http://dbpedia.org/resource/Reoviridae +
, http://dbpedia.org/resource/Lenalidomide +
, http://dbpedia.org/resource/Calgary%2C_Alberta +
, http://dbpedia.org/resource/Carboplatin +
, http://dbpedia.org/resource/Pelareorep +
, http://dbpedia.org/resource/Pancreatic_cancer +
, http://dbpedia.org/resource/Antigen-presenting_cell +
, http://dbpedia.org/resource/Chemokine +
, http://dbpedia.org/resource/Ras_subfamily +
, http://dbpedia.org/resource/Merck_Group +
, http://dbpedia.org/resource/T_cell +
, http://dbpedia.org/resource/Cytokine +
|
| http://dbpedia.org/property/foundation
|
1998
|
| http://dbpedia.org/property/homepage
|
http://www.oncolyticsbiotech.com +
|
| http://dbpedia.org/property/industry
|
Biopharmaceutical
|
| http://dbpedia.org/property/keyPeople
|
Matt Coffey Ph.D. - President, and Chief Executive Officer, Chief Operating Officer; Kirk Look, CA - Chief Financial Officer; Andres A. Gutierrez, M.D., Ph.D. - Chief Medical Officer; Andrew de Guttadauro, President, Oncolytics Biotech Inc.
|
| http://dbpedia.org/property/locationCity
|
http://dbpedia.org/resource/Calgary%2C_Alberta +
|
| http://dbpedia.org/property/locationCountry
|
http://dbpedia.org/resource/Canada +
|
| http://dbpedia.org/property/name
|
Oncolytics Biotech Inc.
|
| http://dbpedia.org/property/products
|
REOLYSIN, a first-in-class intravenously delivered immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies.
|
| http://dbpedia.org/property/tradedAs
|
, NASDAQ:ONCY
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Update +
, http://dbpedia.org/resource/Template:TSX +
, http://dbpedia.org/resource/Template:Authority_control +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_1998 +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_Canada +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Toronto_Stock_Exchange +
|
| http://www.w3.org/2004/02/skos/core#closeMatch
|
http://www.grid.ac/institutes/grid.459870.7 +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Oncolytics_Biotech?oldid=1114886378&ns=0 +
|
| http://xmlns.com/foaf/0.1/homepage
|
http://www.oncolyticsbiotech.com +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Oncolytics_Biotech +
|
| http://xmlns.com/foaf/0.1/name
|
Oncolytics Biotech Inc.
|
| owl:sameAs |
https://global.dbpedia.org/id/NN26 +
, http://yago-knowledge.org/resource/Oncolytics_Biotech +
, http://rdf.freebase.com/ns/m.03p3q1r +
, http://dbpedia.org/resource/Oncolytics_Biotech +
, http://www.wikidata.org/entity/Q13529450 +
|
| rdf:type |
http://dbpedia.org/class/yago/Organization108008335 +
, http://dbpedia.org/class/yago/WikicatPharmaceuticalCompaniesOfCanada +
, http://dbpedia.org/ontology/Company +
, http://dbpedia.org/class/yago/WikicatPharmaceuticalCompaniesEstablishedIn1998 +
, http://dbpedia.org/ontology/Organisation +
, http://dbpedia.org/class/yago/WikicatCompaniesListedOnTheTorontoStockExchange +
, http://dbpedia.org/class/yago/Institution108053576 +
, http://dbpedia.org/class/yago/SocialGroup107950920 +
, http://www.wikidata.org/entity/Q43229 +
, http://www.wikidata.org/entity/Q4830453 +
, http://schema.org/Organization +
, http://dbpedia.org/class/yago/Company108058098 +
, http://dbpedia.org/class/yago/WikicatCompaniesListedOnNASDAQ +
, http://dbpedia.org/ontology/Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://dbpedia.org/class/yago/YagoLegalActor +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
, http://dbpedia.org/class/yago/DrugCompany108002578 +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/Group100031264 +
|
| rdfs:comment |
Oncolytics Biotech Inc. is a Canadian comp … Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.ough innate and adaptive immune responses.
|
| rdfs:label |
Oncolytics Biotech
|
